| Original language | English |
|---|---|
| Pages (from-to) | 603-604 |
| Number of pages | 2 |
| Journal | Neurology |
| Volume | 94 |
| Issue number | 14 |
| DOIs | |
| State | Published - Apr 7 2020 |
Bibliographical note
Funding Information:Supported by the NIH.
Funding Information:
D.C. Park has received investigator-initiated grants from Avid Radiopharmaceuticals, a Division of Eli Lilly and Co. She has also received grant funding from the NIH. E. Abner has received grant funding from the NIH. Go to Neurology.org/N for full disclosures.
Funding
Supported by the NIH. D.C. Park has received investigator-initiated grants from Avid Radiopharmaceuticals, a Division of Eli Lilly and Co. She has also received grant funding from the NIH. E. Abner has received grant funding from the NIH. Go to Neurology.org/N for full disclosures.
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | |
| National Institutes of Health (NIH) |
ASJC Scopus subject areas
- Clinical Neurology